Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
J Foot Ankle Surg ; 55(1): 117-20, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-26419854

RESUMO

Vitamin D is an essential, fat-soluble nutrient that is a key modulator of bone health. Despite the gaining popularity throughout published medical studies, no consensus has been reached regarding a serum vitamin D level that will guarantee adequate skeletal health in a patient with an increased functional demand. The purpose of the present investigation was to examine the serum concentrations of vitamin D in patients with confirmed stress fractures. A total of 124 patients were included in our retrospective cohort study. Of the 124 patients, 53 had vitamin D levels measured within 3 months of diagnosis. An association was seen in patients with a stress fracture and vitamin D level measured, as 44 (83.02%) of the 53 patients had a serum 25-hydroxyvitamin D level <40 ng/mL. Although an association was seen at our institution in patients with stress fractures and a serum vitamin D concentration <40 ng/mL, a larger and prospective investigation is warranted to further understand the effect of vitamin D level and stress fracture prevention in an active, nonmilitary population.


Assuntos
Densidade Óssea/fisiologia , Fraturas de Estresse/sangue , Ossos do Metatarso/lesões , Deficiência de Vitamina D/complicações , Vitamina D/análogos & derivados , Adulto , Feminino , Seguimentos , Fraturas de Estresse/diagnóstico , Fraturas de Estresse/etiologia , Humanos , Imageamento por Ressonância Magnética , Masculino , Estudos Retrospectivos , Fatores de Tempo , Vitamina D/sangue , Deficiência de Vitamina D/sangue
2.
Arterioscler Thromb Vasc Biol ; 34(9): 2151-9, 2014 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-25060790

RESUMO

OBJECTIVE: To explore the role of systemic inflammation in the regulation of adiponectin levels in patients with ischemic heart disease. APPROACH AND RESULTS: In a cross-sectional study of 575 subjects, serum adiponectin was compared between healthy subjects, patients with coronary artery disease with no/mild/severe heart failure (HF), and patients with nonischemic HF. Adiponectin expression and release from femoral, subcutaneous and thoracic adipose tissue was determined in 258 additional patients with coronary artery bypass grafting. Responsiveness of the various human adipose tissue depots to interleukin-6, tumor necrosis factor-α, and brain natriuretic peptide (BNP) was examined by using ex vivo models of human fat. The effects of inducible low-grade inflammation were tested by using the model of Salmonella typhi vaccine-induced inflammation in healthy individuals. In the cross-sectional study, HF strikingly increased adiponectin levels. Plasma BNP was the strongest predictor of circulating adiponectin and its release from all adipose tissue depots in patients with coronary artery bypass grafting, even in the absence of HF. Femoral AT was the depot with the least macrophages infiltration and the largest adipocyte cell size and the only responsive to systemic and ex vivo proinflammatory stimulation (effect reversible by BNP). Low-grade inflammation reduced circulating adiponectin levels, while circulating BNP remained unchanged. CONCLUSIONS: This study demonstrates the regional variability in the responsiveness of human adipose tissue to systemic inflammation and suggests that BNP (not systemic inflammation) is the main driver of circulating adiponectin in patients with advanced atherosclerosis even in the absence of HF. Any interpretation of circulating adiponectin as a biomarker should take into account the underlying disease state, background inflammation, and BNP levels.


Assuntos
Adiponectina/biossíntese , Tecido Adiposo/metabolismo , Insuficiência Cardíaca/metabolismo , Inflamação/metabolismo , Isquemia Miocárdica/metabolismo , Peptídeo Natriurético Encefálico/fisiologia , Adiponectina/genética , Idoso , Artéria Braquial/diagnóstico por imagem , Artéria Braquial/fisiopatologia , Ponte de Artéria Coronária , Doença da Artéria Coronariana/complicações , Doença da Artéria Coronariana/metabolismo , Estudos Transversais , Feminino , Insuficiência Cardíaca/etiologia , Humanos , Interleucina-6/sangue , Interleucina-6/farmacologia , Masculino , Pessoa de Meia-Idade , Isquemia Miocárdica/complicações , Peptídeo Natriurético Encefálico/sangue , Técnicas de Cultura de Órgãos , Especificidade de Órgãos , Fatores de Risco , Gordura Subcutânea , Coxa da Perna , Tórax , Fator de Necrose Tumoral alfa/farmacologia , Ultrassonografia , Vasodilatação , Disfunção Ventricular Esquerda/etiologia , Disfunção Ventricular Esquerda/fisiopatologia
3.
Foot Ankle Spec ; : 19386400221101950, 2022 Jun 22.
Artigo em Inglês | MEDLINE | ID: mdl-35730534

RESUMO

Minimally invasive surgery (MIS) is a growing technique that favors faster recovery and cosmetic results. We propose a recommended osteotomy position or "MIS Sweet Spot" to make the procedure more reproducible and lessen the learning curve to improve outcomes. A total of 211 patients from 3 surgeons between 2 different study centers were included in a retrospective radiograph measurement analysis and a cadaveric dissection to confirm the safety of nearby anatomical structures. An average distance of 2.2 cm proximal from the first metatarsophalangeal joint was found as the "Sweet Spot" to perform the transverse osteotomy. At this distance, neurovascular and tendinous structures were unharmed and the osteotomy remained extracapsular. Furthermore, an average of 10.7° of intermetatarsal angle reduction and a reduction of tibial sesamoid position of 3 points were achieved. A predictable and measurable distance for osteotomy placement will help to provide more confidence in producing the bunionectomy osteotomy with the specialized tools used in MIS and can help to reduce operative time and improve results.Level of Clinical Evidence (LOCE): 3.

4.
J Am Coll Cardiol ; 63(23): 2491-2502, 2014 Jun 17.
Artigo em Inglês | MEDLINE | ID: mdl-24613322

RESUMO

Atherosclerosis, the main pathophysiological condition leading to cardiovascular disease (CVD), is now considered to be a chronic inflammatory condition. Statins are the most widely used and promising agents in treating CVD and are renowned for their pleiotropic lipid-lowering independent effects. Statins exert their anti-inflammatory effects on the vascular wall through a variety of molecular pathways of the innate and adaptive immune systems, their impact on the circulating levels of pro-inflammatory cytokines, and their effect on adhesion molecules. By inhibiting the mevalonate pathway and isoprenoid formation, statins account for the increase of nitric oxide bioavailability and the improvement of vascular and myocardial redox state by multiple different mechanisms (directly or indirectly through low-density lipoprotein [LDL] lowering). A large number of randomized control trials have shown that statins help in the primary and secondary prevention of cardiovascular events, not only via their lipid-lowering effect, but also due to their anti-inflammatory potential as well. In this paper, we examine the molecular pathways in which statins are implicated and exert their anti-inflammatory effects, and we focus specifically on their impact on innate and adaptive immunity systems. Finally, we review the most important clinical data for the role of statins in primary and secondary prevention of cardiovascular events.


Assuntos
Imunidade Adaptativa/efeitos dos fármacos , Aterosclerose/tratamento farmacológico , Inibidores de Hidroximetilglutaril-CoA Redutases/uso terapêutico , Imunidade Inata/efeitos dos fármacos , Inflamação/tratamento farmacológico , Miocardite/tratamento farmacológico , Aterosclerose/complicações , Aterosclerose/imunologia , Humanos , Inflamação/etiologia , Inflamação/imunologia , Miocardite/etiologia , Miocardite/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA